Flexible nets: The roles of intrinsic disorder in protein interaction networks

FEBS Journal

Volumn 272, Issue 20, 2005, Pages 5129-5148

  Dunker, A Keith ^a   Cortese, Marc S ^a   Romero, Pedro ^a,b   Iakoucheva, Lilia M ^c   Uversky, Vladimir N ^a,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

AMINO ACID SEQUENCE; BINDING AFFINITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SCALE UP; SHORT SURVEY;

ANIMALS; BINDING SITES; CALMODULIN; CELL PHYSIOLOGY; CYCLIN-DEPENDENT KINASES; GLYCOGEN SYNTHASE KINASE 3; HMGA PROTEINS; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTEINS; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 27144464910     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04948.x     Document Type: Short Survey

References (205)

1. Goh KI, Oh E, Jeong H, Kahng B & Kim D (2002) Classification of scale-free networks. Proc Natl Acad Sci USA 99, 12583-12588.
2. Jeong H, Tombor B, Albert R, Oltvai ZN & Barabasi AL (2000) The large-scale organization of metabolic networks. Nature 407, 651-654.
3. Barabasi AL & Albert R (1999) Emergence of scaling in random networks. Science 286, 509-512.
4. Watts DJ & Strogatz SH (1998) Collective dynamics of 'small-world' networks. Nature 393, 440-442.
5. Barabasi AL & Bonabeau E (2003) Scale-free networks. Sci Am 288, 60-69.
6. Erdös P & Rényi A (1960) On the evolution of random graphs. Publ Math Inst Hung Acad Sci 5, 17-61.
7. Albert R, Jeong H & Barabasi AL (2000) Error and attack tolerance of complex networks. Nature 406, 378-382.
8. Milgram S (1967) The small world problem. Psycol Today 2, 60-67.
9. Jeong H, Mason SP, Barabasi AL & Oltvai ZN (2001) Lethality and centrality in protein networks. Nature 411, 41-42.
10. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M & Sakaki Y (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA 98, 4569-4574.
11. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A, Li Y, Godwin B, Conover D, Kalbfleisch T, Vijayadamodar G, Yang M, Johnston M, Fields S & Rothberg JM (2000) A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403, 623-627.
12. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, Boxern M, Vidalain PO, Han JD, Chesneau A, Hao T et al. (2004) A map of the interactome network of the metazoan C. elegans. Science 303, 540-543.
13. Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y, Hao YL, Ooi CE, Godwin B, Vitols E et al. (2003) A protein interaction map of Drosophila melanogaster. Science 302, 1727-1736.
14. Han JD, Dupuy D, Bertin N, Cusick ME & Vidal M (2005) Effect of sampling on topology predictions of protein-protein interaction networks. Nat Biotechnol 23, 839-844.
15. Bork P, Jensen LJ, von Mering C, Ramani AK, Lee I & Marcotte EM (2004) Protein interaction networks from yeast to human. Curr Opin Struct Biol 14, 292-299.
16. Cesareni G, Ceol A, Gavrila C, Palazzi LM, Persico M & Schneider MV (2005) Comparative interactomics. FEBS Lett 579, 1828-1833.
17. von Mering C, Krause R, Snel B, Cornell M, Oliver SG, Fields S & Bork P (2002) Comparative assessment of large-scale data sets of protein-protein interactions. Nature 417, 399-403.
18. Bader GD & Hogue CW (2002) Analyzing yeast protein-protein interaction data obtained from different sources. Nat Biotechnol 20, 991-997.
19. Hoffmann R & Valencia A (2003) Protein interaction: same network, different hubs. Trends Genet 19, 681-683.
20. Wu CH, Huang H, Nikolskaya A, Hu Z & Barker WC (2004) The iProClass integrated database for protein functional analysis. Comput Biol Chem 28, 87-96.
21. Huang TW, Tien AC, Huang WS, Lee YC, Peng CL, Tseng HH, Kao CY & Huang CY (2004) POINT: a database for the prediction of protein-protein interactions based on the orthologous interactome. Bioinformatics 20, 3273-3276.
22. Kelley BP, Yuan B, Lewitter F, Sharan R, Stockwell BR & Ideker T (2004) PathBLAST: a tool for alignment of protein interaction networks. Nucleic Acids Res 32, W83-W88.
23. von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, Jouffre N, Huynen MA & Bork P (2005) STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res 33, D433-D437.
24. Hahn MW & Kern AD (2005) Comparative genomics of centrality and essentiality in three eukaryotic protein interaction networks. Mol Biol Evol 22, 803-806.
25. Huang S (2004) Back to the biology in systems biology: what can we learn from biomolecular networks? Brief Fund Genomic Proteomic 2, 279-297.
26. Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP & Vidal M (2004) Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430, 88-93.
27. Hartwell LH, Hopfield JJ, Leibler S & Murray AW (1999) From molecular to modular cell biology. Nature 402, C47-C52.
28. Fischer E (1894) Einfluss der configuration auf die wirkung derenzyme. Ber Dt Chem Ges 27, 2985-2993.
29. Koshland DE Jr, Ray WJ Jr & Erwin MJ (1958) Protein structure and enzyme action. Fed Proc 17, 1145-1150.
30. Hasty J & Collins JJ (2001) Protein interactions. Unspinning the web. Nature 411, 30-31.
31. Gunasekaran K, Tsai CJ, Kumar S, Zanuy D & Nussinov R (2003) Extended disordered proteins: targeting function with less scaffold. Trends Biochem Sci 28, 81-85.
32. Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM & Obradovic Z (2002) Intrinsic disorder and protein function. Biochemistry 41, 6573-6582.
33. Dunker AK, Brown CJ & Obradovic Z (2002) Identification and functions of usefully disordered proteins. Adv Protein Chem 62, 25-49.
34. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, Oldfield CJ, Campen AM, Ratliff CM, Hipps KW et al. (2001) Intrinsically disordered protein. J Mol Graph Model 19, 26-59.
35. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z & Dunker AK (2002) Intrinsic disorder in cell-signaling and cancer-associated proteins. J Mol Biol 323, 573-584.
36. Uversky VN (2003) Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go? Cell Mol Life Sci 60, 1852-1871.
37. Uversky VN (2002) Natively unfolded proteins: a point where biology waits for physics. Protein Sci 11, 739-756.
38. Uversky VN (2002) What does it mean to be natively unfolded? Eur J Biochem 269, 2-12.
39. Dyson HJ & Wright PE (2002) Coupling of folding and binding for unstructured proteins. Curr Opin Struct Biol. 12, 54-60.
40. Dyson HJ & Wright PE (2005) Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6, 197-208.
41. Wright PE & Dyson HJ (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol 293, 321-331.
42. Namba K (2001) Roles of partly unfolded conformations in macromolecular self-assembly. Genes Cells 6, 1-12.
43. Demchenko AP (2001) Recognition between flexible protein molecules: induced and assisted folding. J Mol Recognit 14, 42-61.
44. Tompa P (2002) Intrinsically unstructured proteins. Trends Biochem Sci 27, 527-533.
45. Tompa P (2003) Intrinsically unstructured proteins evolve by repeat expansion. Bioessays 25, 847-855.
46. Bracken C, Iakoucheva LM, Romero PR & Dunker AK (2004) Combining prediction, computation and experiment for the characterization of protein disorder. Curr Opin Struct Biol 14, 570-576.
47. Fink AL (2005) Natively unfolded proteins. Curr Opin Struct Biol 15, 35-41.
48. Uversky VN, Oldfield CJ & Dunker AK (2005) Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J Mol Recognit 18, 343-384.
49. Dunker AK & Obradovic Z (2001) The protein trinity - linking function and disorder. Nat Biotechnol 19, 805-806.
50. Uversky VN, Gillespie JR & Fink AL (2000) Why are 'natively unfolded' proteins unstructured under physiologic conditions? Proteins 41, 415-427.
51. Daughdrill GW, Pielak GJ, Uversky VN, Cortese MS & Dunker AK (2005) Natively disordered proteins. In Handbook of Protein Folding (Buchner J & Kiefhaber T, eds), pp. 271-353. Wiley-VCH-Verlag GmbH KGaA, Weinheim, Germany.
52. Romero P, Obradovic Z, Kissinger C, Villafranca JE & Dunker AK (1997) Identifying disordered regions in proteins from amino acid sequence. Proceedings of International Conference on Neural Networks 1, 90-95.
53. Obradovic Z, Peng K, Vucetic S, Radivojac P, Brown CJ & Dunker AK (2003) Predicting intrinsic disorder from amino acid sequence. Proteins 53 (Suppl. 6), 566-572.
54. Romero P, Obradovic Z & Dunker AK (1997) Sequence data analysis for long disordered regions prediction in the calcineurin family. Genome Inform Ser Workshop Genome Inform 8, 110-124.
55. Romero P, Obradovic Z, Kissinger CR, Villafranca JE, Garner E, Guilliot S & Dunker AK (1998) Thousands of proteins likely to have long disordered regions. Pac Symp Biocomput 437-448.
56. Dunker AK, Garner E, Guilliot S, Romero P, Albrecht K, Hart J, Obradovic Z, Kissinger C & Villafranca JE (1998) Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac Symp Biocomput 473-484.
57. Romero P, Obradovic Z, Li X, Garner EC, Brown CJ & Dunker AK (2001) Sequence complexity of disordered protein. Proteins 42, 38-48.
58. Vucetic S, Brown CJ, Dunker AK & Obradovic Z (2003) Flavors of protein disorder. Proteins 52, 573-584.
59. Li X, Romero P, Rani M, Dunker AK & Obradovic Z (1999) Predicting Protein Disorder for N-, C-, and Internal Regions. Genome Inform Series Workshop Genome Inform 10, 30-40.
60. Dunker AK, Obradovic Z, Romero P, Garner EC & Brown CJ (2000) Intrinsic protein disorder in complete genomes. Genome Inform Series Workshop Genome Inform 11, 161-171.
61. Oldfield CJ, Cheng Y, Cortese MS, Brown CJ, Uversky VN & Dunker AK (2005) Comparing and combining predictors of mostly disordered proteins. Biochemistry 44, 1989-2000.
62. Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF & Jones DT (2004) Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol 337, 635-645.
63. Liu J & Rost B (2001) Comparing function and structure between entire proteomes. Protein Sci 10, 1970-1979.
64. Sigler PB (1988) Transcriptional activation. Acid blobs and negative noodles. Nature 333, 210-212.
65. Schulz GE (1979) Nucleotide binding proteins. In Molecular Mechanism of Biological Recognition (Balaban M, ed.), pp. 79-94. Elsevier/North-Holland Biomedical Press, New York.
66. Kriwacki RW, Hengst L, Tennant L, Reed SI & Wright PE (1996) Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc Natl Acad Sci USA 93, 11504-11509.
67. Dajani R, Fraser E, Roe SM, Yeo M, Good VM, Thompson V, Dale TC & Pearl LH (2003) Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex. Embo J 22, 494-501.
68. Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG & Reith AD (2001) The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure (Camb) 9, 1143-1152.
69. Ding Y & Dale T (2002) Wnt signal transduction: kinase cogs in a nano-machine? Trends Biochem Sci 27, 327-329.
70. Polakis P (2000) Wnt signaling and cancer. Genes Dev 14, 1837-1851.
71. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B & Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512.
72. Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ & Woodgett JR (1992) Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1114, 147-162.
73. Ross SE, Erickson RL, Hemati N & MacDougald OA (1999) Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase. Mol Cell Biol 19, 8433-8441.
74. Cohen P (1999) The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction. Philos Trans R Soc Lond B Biol Sci 354, 485-495.
75. Cross DA, Alessi DR, Cohen P, Andjelkovich M & Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
76. Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC & Pearl LH (2001) Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732.
77. Hsu W, Zeng L & Costantini F (1999) Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. J Biol Chem 274, 3439-3445.
78. Seeling JM, Miller JR, Gil R, Moon RT, White R & Virshup DM (1999) Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283, 2089-2091.
79. Grosschedl R, Giese K & Pagel J (1994) HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 10, 94-100.
80. Reeves R (2001) Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277, 63-81.
81. Lehn DA, Elton TS, Johnson KR & Reeves R (1988) A conformational study of the sequence specific binding of HMG-I(Y) with the bovine interleukin-2 cDNA. Biochem Int 16, 963-971.
82. Evans JN, Nissen MS & R (1992) Assignment of the 1H NMR spectrum of a consensus DNA-binding peptide from the HMG-1 protein. Bull Mag Reson 14, 171-174.
83. Evans JN, Zajicek J, Nissen MS, Munske G, Smith V & Reeves R (1995) 1H and 13C NMR assignments and molecular modelling of a minor groove DNA-binding peptide from the HMG-I protein. Int J Pept Protein Res 45, 554-560.
84. Lund T, Holtlund J, Fredriksen M & Laland SG (1983) On the presence of two new high mobility group-like proteins in HeLa S3 cells. FEBS Lett 152, 163-167.
85. Obradovic Z, Peng K, Vucetic S, Radivojac P & Dunker AK (2005) Exploiting heterogeneous sequence properties improves prediction of protein disorder. Proteins: Struct Func Bioinf in press.
86. Reeves R & Nissen MS (1990) The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem 265, 8573-8582.
87. Huth JR, Bewley CA, Nissen MS, Evans JN, Reeves R, Gronenborn AM & Clore GM (1997) The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat Struct Biol 4, 657-665.
88. Disney JE, Johnson KR, Magnuson NS, Sylvester SR & Reeves R (1989) High-mobility group protein HMG-I localizes to G/Q- and C-bands of human and mouse chromosomes. J Cell Biol 109, 1975-1982.
89. Reeves R (1992) Chromatin changes during the cell cycle. Curr Opin Cell Biol 4, 413-423.
90. Reeves R & Beckerbauer L (2001) HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 1519, 13-29.
91. Varshavsky A, Levinger L, Sundin O, Barsoum J, Ozkaynak E, Swerdlow P & Finley D (1983) Cellular and SV40 chromatin: replication, segregation, ubiquitination, nuclease-hypersensitive sites, HMG-containing nucleosomes, and heterochromatin-specific protein. Cold Spring Harb Symp Quant Biol 47 Part 1, 511-528.
92. Reeves R & Nissen MS (1993) Interaction of high mobility group-I(Y) nonhistone proteins with nucleosome core particles. J Biol Chem 268, 21137-21146.
93. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai BM, Fidanza V, Giancotti V, Santoro M, Simeone A & Fusco A (1996) High level expression of the HMGI(Y) gene during embryonic development. Oncogene 13, 2439-2446.
94. Bustin M & Reeves R (1996) High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 54, 35-100.
95. Friedberg EC, Walker GC & Siede W (1995) DNA Repair and Mutagenesis. ASM Press, Washington, DC.
96. Bootsma D, Kreamer KH, Cleaver JE & Hoeijmakers JHJ (1998) Nucleotide excision repair: xeroderma pigmentosum, Cocayne syndrome, and trichothiodystrophy. In The Genetic Basis of Human Cancer (Vogelstein B & Kinzler KW, eds), pp. 245-274. McGraw-Hill, New York.
97. de Boer J & Hoeijmakers JH (2000) Nucleotide excision repair and human syndromes. Carcinogenesis 21, 453-460.
98. Cleaver JE & States JC (1997) The DNA damage-recognition problem in human and other eukaryotic cells: the XPA damage binding protein. Biochem J 328, 1-12.
99. Jones CJ & Wood RD (1993) Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA. Biochemistry 32, 12096-12104.
100. Asahina H, Kuraoka I, Shirakawa M, Morita EH, Miura N, Miyamoto I, Ohtsuka E, Okada Y & Tanaka K (1994) The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damage. Mutat Res 315, 229-237.
101. Nitta M, Saijo M, Kodo N, Matsuda T, Nakatsu Y, Tamai H & Tanaka K (2000) A novel cytoplasmic GTPase XAB1 interacts with DNA repair protein XPA. Nucleic Acids Res 28, 4212-4218.
102. Nakatsu Y, Asahina H, Citterio E, Rademakers S, Vermeulen W, Kamiuchi S, Yeo JP, Khaw MC, Saijo M, Kodo N, Matsuda T, Hoeijmakers JH & Tanaka K (2000) XAB2, a novel tetratricopeptide repeat protein involved in transcription-coupled DNA repair and transcription. J Biol Chem 275, 34931-34937.
103. Saijo M, Kuraoka I, Masutani C, Hanaoka F & Tanaka K (1996) Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro. Nucleic Acids Res 24, 4719-4724.
104. Li L, Lu X, Peterson CA & Legerski RJ (1995) An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair. Mol Cell Biol 15, 5396-5402.
105. Miyamoto I, Miura N, Niwa H, Miyazaki J & Tanaka K (1992) Mutational analysis of the structure and function of the xeroderma pigmentosum group A complementing protein. Identification of essential domains for nuclear localization and DNA excision repair. J Biol Chem 267, 12182-12187.
106. Nagai A, Saijo M, Kuraoka I, Matsuda T, Kodo N, Nakatsu Y, Mimaki T, Mino M, Biggerstaff M, Wood RD, Sijbers A, Hoeijmakers JHJ & Tanaka K (1995) Enhancement of damage-specific DNA binding of XPA by interaction with the ERCC1 DNA repair protein. Biochem Biophys Res Commun 211, 960-966.
107. Li L, Elledge SJ, Peterson CA, Bales ES & Legerski RJ (1994) Specific association between the human DNA repair proteins XPA and ERCC1. Proc Natl Acad Sci USA 91, 5012-5016.
108. Park CH, Mu D, Reardon JT & Sancar A (1995) The general transcription-repair factor TFIIH is recruited to the excision repair complex by the XPA protein independent of the TFIIE transcription factor. J Biol Chem 270, 4896-4902.
109. Nocentini S, Coin F, Saijo M, Tanaka K & Egly JM (1997) DNA damage recognition by XPA protein promotes efficient recruitment of transcription factor II H. J Biol Chem 272, 22991-22994.
110. Kuraoka I, Morita EH, Saijo M, Matsuda T, Morikawa K, Shirakawa M & Tanaka K (1996) Identification of a damaged-DNA binding domain of the XPA protein. Mutat Res 362, 87-95.
111. Ikegami T, Kuraoka I, Saijo M, Kodo N, Kyogoku Y, Morikawa K, Tanaka K & Shirakawa M (1998) Solution structure of the DNA- and RPA-binding domain of the human repair factor XPA. Nat Struct Biol 5, 701-706.
112. Buchko GW, Ni S, Thrall BD & Kennedy MA (1998) Structural features of the minimal DNA binding domain (M98-F219) of human nucleotide excision repair protein XPA. Nucleic Acids Res 26, 2779-2788.
113. Iakoucheva LM, Kimzey AL, Masselon CD, Bruce JE, Garner EC, Brown CJ, Dunker AK, Smith RD & Ackerman EJ (2001) Identification of intrinsic order and disorder in the DNA repair protein XPA. Protein Sci 10, 560-571.
114. Fontana A, de Laureto PP, Spolaore B, Frare E, Picotti P & Zambonin M (2004) Probing protein structure by limited proteolysis. Acta Biochim Pol 51, 299-321.
115. Fontana A, Polverino de Laureto P, De Filippis V, Scaramella E & Zambonin M (1997) Probing the partly folded states of proteins by limited proteolysis. Fold Des 2, R17-R26.
116. Morgan DO (1995) Principles of CDK regulation. Nature 374, 131-134.
117. Morgan DO (1997) Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13, 261-291.
118. Nigg EA (2001) Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2, 21-32.
119. Pavletich NP (1999) Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol 287, 821-828.
120. Russo AA, Jeffrey PD, Patten AK, Massague J & Pavletich NP (1996) Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331.
121. Byth KF, Cooper N, Culshaw JD, Heaton DW, Oakes SE, Minshull CA, Norman RA, Pauptit RA, Tucker JA, Breed J, Pannifer A, Rowsell S, Stanway JJ, Valentine AL & Thomas AP (2004) Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors. Bioorg Med Chem Lett 14, 2249-2252.
122. Lacy ER, Filippov I, Lewis WS, Otieno S, Xiao L, Weiss S, Hengst L & Kriwacki RW (2004) p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nat Struct Mol Biol 11, 358-364.
123. Harper JW, Adami GR, Wei N, Keyomarsi K & Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
124. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP & Wei N (1995) Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6, 387-400.
125. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P & Massague J (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
126. Toyoshima H & Hunter T (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
127. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW & Elledge SJ (1995) p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9, 650-662.
128. Flaugh SL & Lumb KJ (2001) Effects of macromolecular crowding on the intrinsically disordered proteins c-Fos and p27(Kip1). Biomacromolecules 2, 538-540.
129. Bienkiewicz EA, Adkins JN & Lumb KJ (2002) Functional consequences of preorganized helical structure in the intrinsically disordered cell-cycle inhibitor p27(Kip1). Biochemistry 41, 752-759.
130. Spolar RS & Record MT Jr (1994) Coupling of local folding to site-specific binding of proteins to DNA. Science 263, 777-784.
131. Cohen P & Klee CB (1988) Calmodulin. Elsevier, New York.
132. Vetter SW & Leclerc E (2003) Novel aspects of calmodulin target recognition and activation. Eur J Biochem 270, 404-414.
133. Yap KL, Kim J, Truong K, Sherman M, Yuan T & Ikura M (2000) Calmodulin target database. J Struct Funct Genomics 1, 8-14.
134. Rhoads AR & Friedberg F (1997) Sequence motifs for calmodulin recognition. FASEB J 11, 331-340.
135. Babu YS, Bugg CE & Cook WJ (1988) Structure of calmodulin refined at 2.2 Å resolution. J Mol Biol 204, 191-204.
136. Barbato G, Ikura M, Kay LE, Pastor RW & Bax A (1992) Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. Biochemistry 31, 5269-5278.
137. Fernandez A (2004) Functionality of wrapping defects in soluble proteins: what cannot be kept dry must be conserved. J Mol Biol 337, 477-483.
138. Fernandez A, Colubri A & Berry RS (2002) Three-body correlations in protein folding: the origin of cooperativity. Physica A 307, 235-259.
139. Fernandez A & Scheraga HA (2003) Insufficiently dehydrated hydrogen bonds as determinants of protein interactions. Proc Natl Acad Sci USA 100, 113-118.
140. Fernandez A & Scott LR (2003) Adherence of packing defects in soluble proteins. Phys Rev Lett 91, 018102.
141. Fernandez A & Scott R (2003) Dehydron: a structurally encoded signal for protein interaction. Biophys J 85, 1914-1928.
142. Fernandez A, Scott R & Berry RS (2004) The nonconserved wrapping of conserved protein folds reveals a trend toward increasing connectivity in proteomic networks. Proc Natl Acad Sci USA 101, 2823-2827.
143. Qin H, Lu HH, Wu WB & Li WH (2003) Evolution of the yeast protein interaction network. Proc Natl Acad Sci USA 100, 12820-12824.
144. Fernandez A & Berry RS (2004) Molecular dimension explored in evolution to promote proteomic complexity. Proc Natl Acad Sci USA 101, 13460-13465.
145. Bourhis JM, Johansson K, Receveur-Brechet V, Oldfield CJ, Dunker KA, Canard B & Longhi S (2004) The C-terminal domain of measles virus nucleoprotein belongs to the class of intrinsically disordered proteins that fold upon binding to their physiological partner. Virus Res 99, 157-167.
146. Oldfield CJ (2002) Predictions of disordered proteins and protein binding regions: applications to structural genomics. Honors Thesis, Washington State University Pullman, Washington.
147. Oldfield CJ, Cheng Y, Cortese MS, Romero P, Uversky VN & Dunker AK (2005) Coupled folding and binding with α-helix-forming molecular recognition elements. Biochemistry 44, 12454-12470.
148. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN & Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28, 235-542.
149. Garner E, Romero P, Dunker AK, Brown C & Obradovic Z (1999) Predicting Binding Regions within Disordered Proteins. Genome Inform Series Workshop Genome Inform 10, 41-50.
150. Callaghan AJ, Aurikko JP, Hag LL, Gunter Grossmann J, Chandran V, Kuhnel K, Poljak L, Carpousis AJ, Robinson CV, Symmons MF & Luisi BF (2004) Studies of the RNA degradosome-organizing domain of the Escherichia coli ribonuclease RNase E. J Mol Biol 340, 965-979.
151. Wagner A (2001) The yeast protein interaction network evolves rapidly and contains few redundant duplicate genes. Mol Biol Evol 18, 1283-1292.
152. Ideker T, Ozier O, Schwikowski B & Siegel AF (2002) Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 18 (Suppl. 1), S233-S240.
153. Galitski T (2004) Molecular networks in model systems. Annu Rev Genomics Hum Genet 5, 177-187.
154. Weinreb PH, Zhen W, Poon AW, Conway KA & Lansbury PT Jr (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 13709-13715.
155. Dev KK, van der Putten H, Sommer B & Rovelli G (2003) Part I: parkin-associated proteins and Parkinson's disease. Neuropharmacology 45, 1-13.
156. Dev KK, Hofele K, Barbieri S, Buchman VL & van der Putten H (2003) Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology 45, 14-44.
157. Lynch WP, Riseman VM & Bretscher A (1987) Smooth muscle caldesmon is an extended flexible monomeric protein in solution that can readily undergo reversible intra- and intermolecular sulfhydryl cross-linking. A mechanism for caldesmon's F-actin bundling activity. J Biol Chem 262, 7429-7437.
158. Gerthoffer WT (2005) Signal-transduction pathways that regulate visceral smooth muscle function III. Coupling of muscarinic receptors to signaling kinases and effector proteins in gastrointestinal smooth muscles. Am J Physiol Gastrointest Liver Physiol 288, G849-G853.
159. Polyakov AA, Huber PA, Marston SB & Gusev NB (1998) Interaction of isoforms of S100 protein with smooth muscle caldesmon. FEBS Lett 422, 235-239.
160. Huber PA (1997) Caldesmon. Int J Biochem Cell Biol 29, 1047-1051.
161. Reeves R & Nissen MS (1999) Purification and assays for high mobility group HMG-I(Y) protein function. Methods Enzymol 304, 155-188.
162. Sgarra R, Tessari MA, Di Bernardo J, Rustighi A, Zago P, Liberatori S, Armini A, Bini L, Giancotti V & Manfioletti G (2005) Discovering high mobility group A molecular partners in tumour cells. Proteomics 5, 1494-1506.
163. Fasshauer D, Otto H, Eliason WK, Jahn R & Brunger AT (1997) Structural changes are associated with soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor complex formation. J Biol Chem 272, 28036-28041.
164. Perez-Branguli F, Muhaisen A & Blasi J (2002) Munc 18a binding to syntaxin 1A and 1B isoforms defines its localization at the plasma membrane and blocks SNARE assembly in a three-hybrid system assay. Mol Cell Neurosci 20, 169-180.
165. Annaert WG, Becker B, Kistner U, Reth M & Jahn R (1997) Export of cellubrevin from the endoplasmic reticulum is controlled by BAP31. J Cell Biol 139, 1397-1410.
166. Weir ML, Klip A & Trimble WS (1998) Identification of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed protein that binds to VAMP. Biochem J 333, 247-251.
167. Nishimura Y, Hayashi M, Inada H & Tanaka T (1999) Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochem Biophys Res Commun 254, 21-26.
168. Ravichandran V, Chawla A & Roche PA (1996) Identification of a novel syntaxin- and synaptobrevin/VAMP-binding protein, SNAP-23, expressed in non-neuronal tissues. J Biol Chem 271, 13300-13303.
169. Mark WY, Liao JC, Lu Y, Ayed A, Laister R, Szymczyna B, Chakrabartty A & Arrowsmith CH (2005) Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? J Mol Biol 345, 275-287.
170. Yoshida K & Miki Y (2004) Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci 95, 866-871.
171. Saijo M, Matsuda T, Kuraoka I & Tanaka K (2004) Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH. Biochem Biophys Res Commun 321, 815-822.
172. Warnmark A, Wikstrom A, Wright AP, Gustafsson JA & Hard T (2001) The N-terminal regions of estrogen receptor alpha and beta are unstructured in vitro and show different TBP binding properties. J Biol Chem 276, 45939-45944.
173. Liu G, Schwartz JA & Brooks SC (2000) Estrogen receptor protects p53 from deactivation by human double minute-2. Cancer Res 60, 1810-1814.
174. Fan S, Wang J, Yuan R, Ma Y, Meng Q, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID & Rosen EM (1999) BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284, 1354-1356.
175. Garcia Pedrero JM, Del Rio B, Martinez-Campa C, Muramatsu M, Lazo PS & Ramos S (2002) Calmodulin is a selective modulator of estrogen receptors. Mol Endocrinol 16, 947-960.
176. Chang J, Kim DH, Lee SW, Choi KY & Sung YC (1995) Transactivation ability of p53 transcriptional activation domain is directly related to the binding affinity to TATA-binding protein. J Biol Chem 270, 25014-25019.
177. Derbyshire DJ, Basu BP, Serpell LC, Joo WS, Date T, Iwabuchi K & Doherty AJ (2002) Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J 21, 3863-3872.
178. Joerger AC, Allen MD & Fersht AR (2004) Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations. J Biol Chem 279, 1291-1296.
179. Kuszewski J, Gronenborn AM & Clore GM (1999) Improving the packing and accuracy of NMR structures with a pseudopotential for the radius of gyration. J Am Chem Soc 121, 2337-2338.
180. Sengupta S & Harris CC (2005) p53: traffic cop at the crossroads of DNA repair and recombination. Nat Rev Mol Cell Biol 6, 44-55.
181. Uhrinova S, Uhrin D, Powers H, Watt K, Zheleva D, Fischer P, McInnes C & Barlow PN (2005) Structure of free MDM2 N-terminal domain reveals conformational adjustments that accompany p53-binding. J Mol Biol 350, 587-598.
182. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ & Pavletich NP (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948-953.
183. Bothner B, Lewis WS, DiGiammarino EL, Weber JD, Bothner SJ & Kriwacki RW (2001) Defining the molecular basis of Arf and Hdm2 interactions. J Mol Biol 314, 263-277.
184. Iwakuma T & Lozano G (2003) MDM2, an introduction. Mol Cancer Res 1, 993-1000.
185. Kissinger CR, Parge HE, Knighton DR, Lewis CT, Pelletier LA, Tempczyk A,
186. Im SH & Rao A (2004) Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. Mol Cells 18, 1-9.
187. Genesca L, Aubareda A, Fuentes JJ, Estivill X, De La Luna S & Perez-Riba M (2003) Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life. Biochem J 374, 567-575.
188. Sun L, Youn HD, Loh C, Stolow M, He W & Liu JO (1998) Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity 8, 703-711.
189. Banerjee A, Banks AS, Nawijn MC, Chen XP & Rothman PB (2002) Cutting edge: Suppressor of cytokine signaling 3 inhibits activation of NFATp. J Immunol 168, 4277-4281.
190. Frey N, Richardson JA & Olson EN (2000) Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci USA 97, 14632-14637.
191. Rittinger K, Budman J, Xu J, Volinia S, Cantley LC, Smerdon SJ, Gamblin SJ & Yaffe MB (1999) Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol Cell 4, 153-166.
192. Fu H, Subramanian RR & Masters SC (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40, 617-647.
193. Dehde S, Rohaly G, Schub O, Nasheuer HP, Bohn W, Chemnitz J, Deppert W & Dornreiter I (2001) Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication. Mol Cell Biol 21, 2581-2593.
194. Ruffner H, Jiang W, Craig AG, Hunter T & Verma IM (1999) BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol Cell Biol 19, 4843-4854.
195. Morton WM, Ayscough KR & McLaughlin PJ (2000) Latrunculin alters the actin-monomer subunit interface to prevent polymerization. Nat Cell Biol 2, 376-378.
196. Schutt CE, Myslik JC, Rozycki MD, Goonesekere NC & Lindberg U (1993) The structure of crystalline profilin-beta-actin. Nature 365, 810-816.
197. Ballweber E, Galla M, Aktories K, Yeoh S, Weeds AG & Mannherz HG (2001) Interaction of ADP-ribosylated actin with actin binding proteins. FEBS Lett 508, 131-135.
198. Xia Z & Storm DR (2005) The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci 6, 267-276.
199. Takahashi K, Hiwada K & Kokubu T (1988) Vascular smooth muscle calponin. A novel troponin T-like protein. Hypertension 11, 620-626.
200. Gusev NB (2001) Some properties of caldesmon and calponin and the participation of these proteins in regulation of smooth muscle contraction and cytoskeleton formation. Biochemistry (Mosc) 66, 1112-1121.
201. Bader GD, Betel D & Hogue CW (2003) BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 31, 248-250.
202. Salwinski L, Miller CS, Smith AJ, Pettit FK, Bowie JU & Eisenberg D (2004) The Database of Interacting Proteins: 2004 update. Nucleic Acids Res 32, D449-D451.
203. von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, Jouffre N, Huynen MA & Bork P (2005) STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res 33, D433-D437.
204. Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V, Muthusamy B, Gandhi TK, Chandrika KN, Deshpande N, Suresh S et al. (2004) Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res 32, D497-D501.
205. Barabasi AL (2001) The physics of the Web. Physics World 14, 33-38.